Skip to main content

Diagnostic options Β· UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 91–105 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5624
AIFM1 Gene Deafness, X-Linked Type 5 Genetic Test

This genetic test analyzes the AIFM1 gene to identify mutations associated with X-linked deafness type 5 and related auditory neuropathy.

Peripheral whole blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AIFM1 gene variants", "Single nucleotide variants", "Insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["No fasting required", "Provide detailed family pedigree", "Provide recent audiology reports"]
Indications
["Diagnosis of X-linked deafness type 5 (DFNX5)", "Evaluation of auditory neuropathy spectrum disorder", "Genetic counselling for families with X-linked hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81294-9 ICD-10: H90.3
Clinical summary
This genetic test analyzes the AIFM1 gene to identify mutations associated with X-linked deafness type 5 and related auditory neuropathy.
TEST-4760
AIMP1 Gene Leukodystrophy Hypomyelinating Typeβ€―3 Genetic Test

This genetic test sequences the entire AIMP1 gene using Next-Generation Sequencing (NGS) to identify mutations associated with Leukodystrophy, Hypomyelinating Type 3 (HLD3).

Peripheral Whole Blood (2 mL) 3–4 working weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AIMP1 gene sequence", "Pathogenic variants in AIMP1"]
Parameters
[]
Preparation
["Inform phlebotomist of all medications and supplements"]
Indications
["Diagnosis of Leukodystrophy, Hypomyelinating Type 3 (HLD3)", "Carrier screening", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88866-1 ICD-10: G37.8
Clinical summary
This genetic test sequences the entire AIMP1 gene using Next-Generation Sequencing (NGS) to identify mutations associated with Leukodystrophy, Hypomyelinating Type 3 (HLD3).
TEST-1925
AIP Gene Germline Mutation Analysis (NGS) for ACTH-Secreting Pituitary Adenoma Test

This test analyzes the AIP gene for germline mutations associated with hereditary pituitary adenomas, particularly ACTH-secreting types.

Peripheral Whole Blood (5–10 mL EDTA) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AIP gene coding regions", "AIP gene splice-site boundaries"]
Parameters
[]
Preparation
["8-hour fast recommended", "Inform team about anticoagulant or antiplatelet medications", "Mandatory pre-test genetic counselling session"]
Indications
["Individuals with early-onset pituitary adenoma (
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-1 ICD-10: E24.0
Clinical summary
This test analyzes the AIP gene for germline mutations associated with hereditary pituitary adenomas, particularly ACTH-secreting types.
TEST-5327
AIRE Gene Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1) Genetic Test

This genetic test sequences the AIRE gene to detect pathogenic variants associated with Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1). It identifies mutations linked to mul...

Whole Blood (Peripheral) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AIRE gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Patients presenting with symptoms suggestive of APS-1", "Family members of affected individuals seeking carrier screening or prenatal planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82900-9 ICD-10: E31.0
Clinical summary
This genetic test sequences the AIRE gene to detect pathogenic variants associated with Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1). It identifies mutations linked to multiple endocrine deficiencies and chronic candidiasis.
TEST-4585
AK2 Gene Reticular Dysgenesis Genetic Test

This genetic test identifies pathogenic variants in the AK2 gene, confirming a diagnosis of reticular dysgenesis.

Whole Blood (EDTA) or DNA FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AK2 gene coding region", "AK2 gene splice-site junctions"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session", "Obtain informed consent"]
Indications
["Suspected severe combined immunodeficiency (SCID)", "Family history of reticular dysgenesis", "Evaluation for hematopoietic stem cell transplantation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101371-1 ICD-10: D81.0
Clinical summary
This genetic test identifies pathogenic variants in the AK2 gene, confirming a diagnosis of reticular dysgenesis.
TEST-4217
AKAP9 Gene Long QT Syndrome Type 11 Genetic Test

This genetic test analyzes the AKAP9 gene to detect variants associated with Long QT syndrome type 11 (LQT11), a condition increasing the risk of cardiac arrhythmias and sudden dea...

Peripheral Whole Blood (EDTA) or Saliva 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AKAP9 gene coding region variants", "Pathogenic variants associated with LQT11"]
Parameters
[]
Preparation
["Maintain current medications unless directed otherwise", "Inform phlebotomist of bleeding disorders or anticoagulant therapy"]
Indications
["Diagnosis of Long QT syndrome type 11", "Risk assessment for sudden cardiac death", "Family screening for LQT11"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92884-7 ICD-10: I45.81
Clinical summary
This genetic test analyzes the AKAP9 gene to detect variants associated with Long QT syndrome type 11 (LQT11), a condition increasing the risk of cardiac arrhythmias and sudden death.
TEST-3436
AKR1C4 Gene Sequencing (46,XY Sex Reversal Typeβ€―8 Modifier) Test

This test evaluates the AKR1C4 gene for pathogenic variants associated with 46,XY sex reversal type 8.

Peripheral whole blood 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["AKR1C4 gene sequence", "Pathogenic variants in coding exons and splice sites"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant family history"]
Indications
["Diagnosis of 46,XY sex reversal type 8", "Genetic counseling for families with affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: E25.8, Q56.1
Clinical summary
This test evaluates the AKR1C4 gene for pathogenic variants associated with 46,XY sex reversal type 8.
TEST-2104
AKT1 Gene Cowden Syndrome Type 6 Genetic Test

This genetic test identifies pathogenic germline variants in the AKT1 gene associated with an increased risk of hereditary cancers, particularly Cowden syndrome type 6.

Peripheral whole blood (DNA FTA card) 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic germline variants in the AKT1 gene", "Copy Number Variants (CNVs) within the AKT1 gene"]
Parameters
[]
Preparation
["No fasting required", "Mandatory pre-test genetic counseling session required before sample collection"]
Indications
["Individuals with a personal or family history suggestive of Cowden syndrome", "Risk assessment for hereditary breast, thyroid, or endometrial cancer predisposition"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96504-5 ICD-10: Q85.8
Clinical summary
This genetic test identifies pathogenic germline variants in the AKT1 gene associated with an increased risk of hereditary cancers, particularly Cowden syndrome type 6.
TEST-6328
AKT2 Gene Diabetes Mellitus, Noninsulin-Dependent, Genetic Test

This genetic test identifies pathogenic variants in the AKT2 gene linked to monogenic noninsulin-dependent diabetes.

Whole Blood (venous draw) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AKT2 gene", "Coding region and splice sites of the AKT2 gene"]
Parameters
[]
Preparation
["No fasting required unless otherwise advised", "Genetic counseling session required before sample collection"]
Indications
["Strong family history of early-onset diabetes", "Diabetes diagnosed before age 40", "Patients not fitting typical type 2 diabetes profiles"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51969-4 ICD-10: E11.9, Z13.1, Z15.81
Clinical summary
This genetic test identifies pathogenic variants in the AKT2 gene linked to monogenic noninsulin-dependent diabetes.
TEST-6180
AKT2 Gene Hypoinsulinemic Hypoglycemia with Hemihypertrophy Genetic Test

This test evaluates the AKT2 gene for pathogenic variants associated with hypoinsulinemic hypoglycemia and hemihypertrophy.

Peripheral whole blood (EDTA tube, 1–3 mL) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["AKT2 gene coding region", "AKT2 gene splice junctions", "AKT2 gene copy number variations"]
Parameters
[]
Preparation
["No fasting required", "Maintain normal diet and hydration", "A light meal before collection is advised", "Signed informed consent form required"]
Indications
["Infants and children with unexplained hypoglycemia", "Patients with hemihypertrophy", "Suspected hypoinsulinemic hypoglycemia with hemihypertrophy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81231-4 ICD-10: E16.1, Q87.3, Z15.89
Clinical summary
This test evaluates the AKT2 gene for pathogenic variants associated with hypoinsulinemic hypoglycemia and hemihypertrophy.
TEST-2607
AKT3 Gene Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 Genetic Test

This genetic test identifies pathogenic variants in the AKT3 gene associated with Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 (MPPH2).

Peripheral Whole Blood (2–3 mL, EDTA tube or DNA FTA card) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AKT3 gene", "Coding exons Β±20 bp splice sites of AKT3"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Infants and children with clinical or MRI features of MPPH2", "Suspected AKT3-related disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-2 ICD-10: Q04.8
Clinical summary
This genetic test identifies pathogenic variants in the AKT3 gene associated with Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome Type 2 (MPPH2).
TEST-6050
ALAD Gene Acute Hepatic Porphyria Genetic Test

This test identifies genetic variants in the ALAD gene responsible for delta-aminolevulinic acid dehydratase deficiency porphyria.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants in ALAD gene", "Indels in ALAD gene", "Copy number variations in ALAD gene"]
Parameters
[]
Preparation
["No fasting required", "No special preparation needed"]
Indications
["Suspected Acute Hepatic Porphyria", "Family history of AHP", "Carrier detection", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 99124-6 ICD-10: E80.29, Z15.09, Z84.81
Clinical summary
This test identifies genetic variants in the ALAD gene responsible for delta-aminolevulinic acid dehydratase deficiency porphyria.
TEST-3323
ALAS2 Gene Anemia, Sideroblastic, X-Linked Genetic Test

This test identifies pathogenic variants in the ALAS2 gene, confirming a diagnosis of X-linked sideroblastic anemia.

Peripheral whole blood (2–5 mL EDTA) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ALAS2 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusion (within 4 weeks)"]
Indications
["Suspected X-linked sideroblastic anemia", "Family screening for ALAS2 mutations", "Genetic counseling for hereditary anemia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81321-9 ICD-10: D64.0
Clinical summary
This test identifies pathogenic variants in the ALAS2 gene, confirming a diagnosis of X-linked sideroblastic anemia.
TEST-5917
ALAS2 Gene Erythropoietic Protoporphyria, X‑Linked Genetic Test

This genetic test identifies gain-of-function mutations in the ALAS2 gene, confirming a diagnosis of X-linked erythropoietic protoporphyria (XLP).

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ALAS2 gene mutations", "Gain-of-function variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected X-linked erythropoietic protoporphyria (XLP)", "Family history of XLP", "Severe photosensitivity unresponsive to standard treatment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21672-8 ICD-10: E80.0
Clinical summary
This genetic test identifies gain-of-function mutations in the ALAS2 gene, confirming a diagnosis of X-linked erythropoietic protoporphyria (XLP).
TEST-3213
ALAS2 Gene Protoporphyria, Erythropoietic, X-linked Genetic Test

This genetic test evaluates the ALAS2 gene for mutations associated with X-linked erythropoietic protoporphyria (XLEPP) and X-linked sideroblastic anemia (XLSA). It identifies path...

Whole Blood (EDTA) or DNA Sample (FTA card or extracted DNA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ALAS2 gene", "Coding region and splice sites of the ALAS2 gene"]
Parameters
[]
Preparation
["No fasting required", "Mandatory pre-test genetic counseling session", "Provide complete medical and family history to the genetic counsellor"]
Indications
["Suspected X-linked erythropoietic protoporphyria (XLEPP)", "Suspected X-linked sideroblastic anemia (XLSA)", "Family history of ALAS2-related disorders", "Carrier screening for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21663-2 ICD-10: E80.0, D64.0
Clinical summary
This genetic test evaluates the ALAS2 gene for mutations associated with X-linked erythropoietic protoporphyria (XLEPP) and X-linked sideroblastic anemia (XLSA). It identifies pathogenic variants to confirm diagnosis and assess carrier status.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area